Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

KCTD4 Inhibitors

KCTD4 inhibitors represent a class of chemical compounds that specifically target the KCTD4 protein, a member of the potassium channel tetramerization domain (KCTD) family. KCTD proteins are a group of proteins that are involved in a variety of cellular processes, including signal transduction, protein degradation, and regulation of ion channels. The KCTD4 protein, in particular, has garnered interest due to its role in modulating various intracellular pathways, particularly those associated with protein-protein interactions and ubiquitination. Inhibitors of KCTD4 function by binding to specific sites on the protein, thereby altering its structural conformation or interfering with its ability to interact with other cellular components. This can lead to changes in the downstream signaling pathways that KCTD4 normally influences, providing a unique biochemical tool for studying these pathways in greater detail. From a chemical perspective, KCTD4 inhibitors are structurally diverse, encompassing a wide range of molecular frameworks that include small organic molecules, peptides, and synthetic derivatives. The design of these inhibitors often involves the identification of key binding pockets or allosteric sites on the KCTD4 protein, followed by the rational development of molecules that can effectively occupy these sites. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and molecular dynamics simulations play a crucial role in elucidating the binding interactions between KCTD4 and its inhibitors, thereby guiding the optimization of inhibitor potency and selectivity. Additionally, these inhibitors may exhibit various mechanisms of action, such as competitive inhibition, where the inhibitor directly competes with the natural substrate for binding, or non-competitive inhibition, where the inhibitor binds to a different site on the protein, affecting its function through conformational changes. The study of KCTD4 inhibitors thus provides valuable insights into the molecular mechanisms underlying KCTD4's role in cellular processes and highlights the potential for these compounds to serve as tools for probing the intricate networks of protein interactions within cells.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tetraethylammonium chloride

56-34-8sc-202834
25 g
$45.00
2
(1)

A potassium channel blocker, may indirectly affect signaling pathways involving KCTD4.

4-Aminopyridine

504-24-5sc-202421
sc-202421B
sc-202421A
25 g
1 kg
100 g
$38.00
$1155.00
$122.00
3
(2)

Blocks voltage-gated potassium channels, potentially influencing pathways where KCTD4 is involved.

Ibutilide Fumarate

122647-32-9sc-211627
10 mg
$255.00
(0)

Modulates potassium channels, potentially affecting KCTD4-associated functions.

Glyburide (Glibenclamide)

10238-21-8sc-200982
sc-200982A
sc-200982D
sc-200982B
sc-200982C
1 g
5 g
25 g
100 g
500 g
$46.00
$61.00
$117.00
$173.00
$530.00
36
(1)

Sulfonylurea compound, inhibits ATP-sensitive potassium channels, possibly affecting KCTD4.

Amiodarone

1951-25-3sc-480089
5 g
$318.00
(1)

Affects multiple ion channels including potassium channels, potentially influencing KCTD4.

Pinacidil monohydrate

85371-64-8sc-203198
sc-203198A
10 mg
50 mg
$51.00
$95.00
6
(1)

Activates ATP-sensitive potassium channels, potentially impacting KCTD4 activity.